Roche Diagnostics GmbH, Penzberg, Germany.
Clinic for Children and Adolescents, University Hospital Erlangen, Erlangen, Germany.
Clin Chem Lab Med. 2023 Mar 24;61(11):1902-1916. doi: 10.1515/cclm-2022-0996. Print 2023 Oct 26.
An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC MS/MS)-based candidate reference measurement procedure (RMP) for aldosterone quantification in human serum and plasma is presented.
The material used in this RMP was characterized by quantitative nuclear magnetic resonance (qNMR) to assure traceability to SI Units. For liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis a two-dimensional heart cut LC approach, in combination with an optimal supported liquid extraction protocol, was established for the accurate analysis of aldosterone in human serum and plasma in order to minimize matrix effects and avoid the co-elution of interferences. Assay validation was performed according to current guidelines. Selectivity and specificity were assessed using spiked serum; potential matrix effects were examined by a post column infusion experiment and the comparison of standard line slopes. An extensive protocol over 5 days was applied to determine precision, accuracy and trueness. Measurement uncertainty was evaluated according to the Guide to the Expression of Uncertainty in Measurement (GUM), for which three individual sample preparations were performed on at least two different days.
The RMP allowed aldosterone quantification within the range of 20-1,200 pg/mL without interference from structurally-related compounds and no evidence of matrix effects. Intermediate precision was ≤4.7% and repeatability was 2.8-3.7% for all analyte concentrations. The bias ranged between -2.2 and 0.5% for all levels and matrices. Total measurement uncertainties for target value assignment (n=6) were found to be ≤2.3%; expanded uncertainties were ≤4.6% (k=2) for all levels.
The RMP showed high analytical performance for aldosterone quantification in human serum and plasma. The traceability to SI units was established by qNMR content determination of aldosterone, which was utilized for direct calibration of the RMP. Thus, this candidate RMP is suitable for routine assay standardization and evaluation of clinical samples.
本文介绍了一种基于同位素稀释-液相色谱-串联质谱(ID-LC-MS/MS)的人血清和血浆中醛固酮定量候选参考测量程序(RMP)。
该 RMP 中使用的材料通过定量核磁共振(qNMR)进行了特征描述,以确保持续溯源至 SI 单位。为了准确分析人血清和血浆中的醛固酮,同时最小化基质效应并避免干扰物共洗脱,采用二维心脏切割 LC 方法结合最佳的支撑液体萃取方案建立了 LC-MS/MS 分析方法。根据现行指南进行了分析验证。通过添加血清评估选择性和特异性;通过柱后输注实验和标准曲线斜率比较检查潜在的基质效应。应用了为期 5 天的广泛方案来确定精密度、准确度和真实性。根据测量不确定度的指南(GUM)评估测量不确定度,其中在至少两天的不同时间对三个单独的样品制备进行了评估。
该 RMP 允许在 20-1200pg/mL 的范围内定量醛固酮,且不会受到结构相关化合物的干扰,也没有证据表明存在基质效应。在所有分析物浓度下,中间精密度均≤4.7%,重复性为 2.8-3.7%。所有水平和基质的偏差范围在-2.2%和 0.5%之间。对于目标值赋值(n=6),总测量不确定度被发现≤2.3%;扩展不确定度为≤4.6%(k=2),适用于所有水平。
该 RMP 显示出在人血清和血浆中定量醛固酮的高分析性能。通过 qNMR 对醛固酮含量的测定建立了与 SI 单位的溯源性,该方法用于直接校准 RMP。因此,该候选 RMP 适合常规分析标准化和临床样本的评估。